News | April 27, 2026
Sun Pharma to acquire Organon in $11.75 billion all-cash deal
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
The deal signals a clear push to expand access to care in underserved regions
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
AI-enabled learning platform to enhance clinical quality, patient outcomes, and staff engagement across Eastern India network
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
Move strengthens footprint in Western India and expands multi-specialty care network
Subscribe To Our Newsletter & Stay Updated
